Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 3 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients.
J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):68-74. doi: 10.1097/MPG.0000000000002304.
J Pediatr Gastroenterol Nutr. 2019.
PMID: 31232885
Free PMC article.
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
Colman RJ, Tsai YT, Jackson K, Boyle BM, Noe JD, Hyams JS, D'Haens GRAM, van Limbergen J, Rosen MJ, Denson LA, Minar P.
Colman RJ, et al.
Inflamm Bowel Dis. 2021 Jun 15;27(7):1045-1051. doi: 10.1093/ibd/izaa241.
Inflamm Bowel Dis. 2021.
PMID: 32944769
Free PMC article.
Item in Clipboard
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease.
Xiong Y, Mizuno T, Colman R, Hyams J, Noe JD, Boyle B, Tsai YT, Dong M, Jackson K, Punt N, Rosen MJ, Denson LA, Vinks AA, Minar P.
Xiong Y, et al.
Clin Pharmacol Ther. 2021 Jun;109(6):1639-1647. doi: 10.1002/cpt.2148. Epub 2021 Jan 7.
Clin Pharmacol Ther. 2021.
PMID: 33354765
Free PMC article.
Item in Clipboard
Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease.
Colman RJ, Samuels A, Mizuno T, Punt N, Vinks AA, Minar P.
Colman RJ, et al.
Inflamm Bowel Dis. 2023 Aug 1;29(8):1342-1346. doi: 10.1093/ibd/izac237.
Inflamm Bowel Dis. 2023.
PMID: 36413113
Free PMC article.
Item in Clipboard
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance.
Colman RJ, Mizuno T, Fukushima K, Haslam DB, Hyams JS, Boyle B, Noe JD, D'Haens GR, Van Limbergen J, Chun K, Yang J, Denson LA, Ollberding NJ, Vinks AA, Minar P.
Colman RJ, et al.
Aliment Pharmacol Ther. 2023 Mar;57(5):524-539. doi: 10.1111/apt.17277. Epub 2022 Oct 31.
Aliment Pharmacol Ther. 2023.
PMID: 36314265
Free PMC article.
Item in Clipboard
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease.
Colman RJ, Xiong Y, Mizuno T, Hyams JS, Noe JD, Boyle B, D'Haens GR, van Limbergen J, Chun K, Yang J, Rosen MJ, Denson LA, Vinks AA, Minar P.
Colman RJ, et al.
Aliment Pharmacol Ther. 2022 Mar;55(5):593-603. doi: 10.1111/apt.16733. Epub 2021 Dec 22.
Aliment Pharmacol Ther. 2022.
PMID: 34935161
Free PMC article.
Item in Clipboard
Cite
Cite